G20 Global Health Summit-United States of America

Examines methodologies for assessing the clinical and economic value of healthcare technologies and interventions. Discussions cover health economic evaluations, cost-effectiveness analysis, and decision-making frameworks for technology adoption and reimbursement. Topics may also include health technology assessment agencies, real-world evidence generation, and the challenges of incorporating patient preferences in economic evaluations.